Quest Diagnostics Incorporated

NYSE:DGX Stok Raporu

Piyasa değeri: US$17.3b

Quest Diagnostics Gelecekteki Büyüme

Future kriter kontrolleri 1/6

Quest Diagnostics kazanç ve gelirin sırasıyla yıllık 11.7% ve 4.8% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 11.1% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 15.5% olacağı tahmin edilmektedir.

Anahtar bilgiler

11.7%

Kazanç büyüme oranı

11.1%

EPS büyüme oranı

Healthcare kazanç büyümesi20.1%
Gelir büyüme oranı4.8%
Gelecekteki özkaynak getirisi15.5%
Analist kapsamı

Good

Son güncelleme27 Oct 2024

Gelecekteki son büyüme güncellemeleri

Earnings Update: Quest Diagnostics Incorporated (NYSE:DGX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Oct 25
Earnings Update: Quest Diagnostics Incorporated (NYSE:DGX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts

Apr 26
Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts

Recent updates

Earnings Update: Quest Diagnostics Incorporated (NYSE:DGX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Oct 25
Earnings Update: Quest Diagnostics Incorporated (NYSE:DGX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat

Oct 24

Why Investors Shouldn't Be Surprised By Quest Diagnostics Incorporated's (NYSE:DGX) P/E

Oct 23
Why Investors Shouldn't Be Surprised By Quest Diagnostics Incorporated's (NYSE:DGX) P/E

Quest Diagnostics: The Better Half Of An Emerging Healthcare Duopoly

Oct 15

These 4 Measures Indicate That Quest Diagnostics (NYSE:DGX) Is Using Debt Reasonably Well

Aug 30
These 4 Measures Indicate That Quest Diagnostics (NYSE:DGX) Is Using Debt Reasonably Well

Should You Think About Buying Quest Diagnostics Incorporated (NYSE:DGX) Now?

Aug 12
Should You Think About Buying Quest Diagnostics Incorporated (NYSE:DGX) Now?

Quest Diagnostics: Beat Down After Beating Q2 Estimates

Jul 28

The Price Is Right For Quest Diagnostics Incorporated (NYSE:DGX)

Jul 12
The Price Is Right For Quest Diagnostics Incorporated (NYSE:DGX)

Quest Diagnostics: On A Quest For Growth

Jul 12

Quest Diagnostics (NYSE:DGX) Hasn't Managed To Accelerate Its Returns

May 14
Quest Diagnostics (NYSE:DGX) Hasn't Managed To Accelerate Its Returns

Quest Diagnostics: Let's Keep Waiting

May 08

Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts

Apr 26
Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts

We Think Quest Diagnostics (NYSE:DGX) Can Stay On Top Of Its Debt

Apr 23
We Think Quest Diagnostics (NYSE:DGX) Can Stay On Top Of Its Debt

Unpleasant Surprises Could Be In Store For Quest Diagnostics Incorporated's (NYSE:DGX) Shares

Apr 02
Unpleasant Surprises Could Be In Store For Quest Diagnostics Incorporated's (NYSE:DGX) Shares

Quest Diagnostics (NYSE:DGX) Is Paying Out A Larger Dividend Than Last Year

Mar 15
Quest Diagnostics (NYSE:DGX) Is Paying Out A Larger Dividend Than Last Year

Quest Diagnostics (NYSE:DGX) Has Announced That It Will Be Increasing Its Dividend To $0.75

Feb 06
Quest Diagnostics (NYSE:DGX) Has Announced That It Will Be Increasing Its Dividend To $0.75

Quest Diagnostics: Post-COVID Normalization Pretty Much Done

Feb 05

Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly

Jan 11
Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly

Why We're Not Concerned About Quest Diagnostics Incorporated's (NYSE:DGX) Share Price

Dec 24
Why We're Not Concerned About Quest Diagnostics Incorporated's (NYSE:DGX) Share Price

Quest Diagnostics: Market Overreaction Creates Investment Opportunity

Dec 08

Is There Now An Opportunity In Quest Diagnostics Incorporated (NYSE:DGX)?

Dec 06
Is There Now An Opportunity In Quest Diagnostics Incorporated (NYSE:DGX)?

Quest Diagnostics' (NYSE:DGX) Returns Have Hit A Wall

Nov 18
Quest Diagnostics' (NYSE:DGX) Returns Have Hit A Wall

Quest Diagnostics: Moving Past Covid

Oct 25

Here's Why Quest Diagnostics (NYSE:DGX) Can Manage Its Debt Responsibly

Sep 25
Here's Why Quest Diagnostics (NYSE:DGX) Can Manage Its Debt Responsibly

What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?

Sep 04
What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?

Quest Diagnostics: Q2 Earnings Reveal Promising Growth Trends Despite Dwindling COVID Testing Revenues

Aug 15

Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward

Aug 13
Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward

Quest Diagnostics Incorporated (NYSE:DGX) Shares Could Be 46% Below Their Intrinsic Value Estimate

Jul 11
Quest Diagnostics Incorporated (NYSE:DGX) Shares Could Be 46% Below Their Intrinsic Value Estimate

Is Quest Diagnostics (NYSE:DGX) A Risky Investment?

Jun 09
Is Quest Diagnostics (NYSE:DGX) A Risky Investment?

Quest Diagnostics: Healthier Diagnosis

May 30

Is It Time To Consider Buying Quest Diagnostics Incorporated (NYSE:DGX)?

May 24
Is It Time To Consider Buying Quest Diagnostics Incorporated (NYSE:DGX)?

Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward

May 09
Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward

An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 24% Undervalued

Mar 22
An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 24% Undervalued

What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?

Feb 19
What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?

Why Quest Diagnostics Isn't A 'Buy', My Oh My

Feb 14

Quest Diagnostics' (NYSE:DGX) Upcoming Dividend Will Be Larger Than Last Year's

Feb 05
Quest Diagnostics' (NYSE:DGX) Upcoming Dividend Will Be Larger Than Last Year's

Kazanç ve Gelir Büyüme Tahminleri

NYSE:DGX - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/202610,9701,0891,3301,70213
12/31/202510,6081,0011,0901,48416
12/31/20249,8349069151,30312
9/30/20249,5398381,0231,397N/A
6/30/20249,3468368751,248N/A
3/31/20249,2878429471,332N/A
12/31/20239,2528508641,272N/A
9/30/20239,2977595961,079N/A
6/30/20239,4887908781,374N/A
3/31/20239,6037898641,332N/A
12/31/20229,8839421,3141,718N/A
9/30/202210,2941,2301,4641,865N/A
6/30/202210,5821,4791,5521,924N/A
3/31/202210,6791,8741,6021,982N/A
12/31/202110,7881,9881,8302,233N/A
9/30/202111,0462,1751,8722,293N/A
6/30/202111,0582,2382,1712,594N/A
3/31/202110,3351,7942,0682,489N/A
12/31/20209,4371,4251,5872,005N/A
9/30/20208,3611,1011,3841,812N/A
6/30/20207,5317498161,249N/A
3/31/20207,6577717791,215N/A
12/31/20197,7268358431,243N/A
9/30/20197,6397098111,190N/A
6/30/20197,5727079291,293N/A
3/31/20197,5387209381,295N/A
12/31/20187,5317338171,200N/A
9/30/20187,5578609141,228N/A
6/30/20187,524808N/A1,188N/A
3/31/20187,469782N/A1,159N/A
12/31/20177,402769N/A1,175N/A
9/30/20177,398671N/A1,156N/A
6/30/20177,427701N/A1,095N/A
3/31/20177,469702N/A1,112N/A
12/31/20167,214642N/A1,116N/A
9/30/20167,503675N/A1,037N/A
6/30/20167,498825N/A948N/A
3/31/20167,517748N/A922N/A
12/31/20157,493706N/A821N/A
9/30/20157,527703N/A852N/A
6/30/20157,551491N/A911N/A
3/31/20157,528507N/A906N/A
12/31/20147,435549N/A944N/A
9/30/20147,308506N/A845N/A
6/30/20147,192780N/A761N/A
3/31/20147,105799N/A689N/A
12/31/20137,146811N/A652N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: DGX 'nin tahmini kazanç büyümesi (yıllık 11.7% ) tasarruf oranının ( 2.5% ) üzerindedir.

Kazançlar ve Piyasa: DGX şirketinin kazançlarının (yıllık 11.7% ) US pazarından (yıllık 15.4% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: DGX şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.

Gelir ve Pazar: DGX şirketinin gelirinin (yıllık 4.8% ) US pazarından (yıllık 8.9% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Geliri: DGX şirketinin gelirinin (yıllık 4.8% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: DGX 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 15.5 %).


Büyüyen şirketleri keşfedin